Trafficking protein particle complex subunit 1 (126-134)

Trafficking protein particle complex subunit 1 (126-134) is a synthetic peptide derived from a specific region of the TRAPPC1 protein, a key component of the trafficking protein particle (TRAPP) complex involved in vesicle-mediated transport within eukaryotic cells. This peptide segment represents amino acids 126 to 134 of the TRAPPC1 sequence and serves as a valuable molecular tool for researchers investigating intracellular trafficking, protein-protein interactions, and the regulation of membrane-bound organelle dynamics. Its defined sequence and biochemical properties make it highly relevant for studies focused on dissecting the mechanistic roles of TRAPPC1 in cellular transport pathways, as well as for broader applications in peptide-based assays and functional analyses.

Peptide interaction studies: Utilization of the TRAPPC1 (126-134) peptide enables detailed mapping of protein-protein interaction domains within the TRAPP complex and its associated partners. By providing a discrete and accessible fragment of the TRAPPC1 subunit, researchers can employ this peptide in pull-down assays, surface plasmon resonance, or co-immunoprecipitation experiments to identify binding affinities and interaction motifs. Such studies are critical for elucidating the molecular determinants underlying vesicle tethering and membrane fusion events, contributing to a deeper understanding of intracellular trafficking regulation.

Antibody production and validation: The defined sequence of this peptide makes it an ideal immunogen for generating polyclonal or monoclonal antibodies specific to the TRAPPC1 (126-134) epitope. These antibodies can be employed in immunoblotting, immunofluorescence, or immunoprecipitation assays to detect endogenous or recombinant TRAPPC1, facilitating precise localization and quantification within cellular and subcellular contexts. Additionally, the peptide serves as a control antigen in antibody validation workflows, ensuring specificity and reliability of immunodetection reagents.

Phosphorylation and post-translational modification studies: As a synthetic substrate, the TRAPPC1 (126-134) peptide can be used in kinase assays or in vitro modification experiments to investigate potential phosphorylation sites or other post-translational modifications within this region of the protein. By monitoring the incorporation of phosphate groups or other modifications, researchers can characterize regulatory mechanisms that modulate TRAPPC1 function and, by extension, the activity of the TRAPP complex in vesicle trafficking.

Epitope mapping: The peptide's well-defined sequence allows for precise epitope mapping applications, particularly in identifying linear antibody binding sites or T-cell epitopes. Through peptide scanning or competitive binding assays, it is possible to delineate regions of immunological significance within TRAPPC1, which is valuable for both basic immunological research and the development of peptide-based detection reagents.

Peptide-based assay development: The TRAPPC1 (126-134) fragment provides a robust tool for the design of custom peptide-based assays, such as enzyme-linked immunosorbent assays (ELISAs), fluorescence polarization, or mass spectrometry-based quantification methods. Its application in these platforms supports quantitative and qualitative analyses of protein interactions, post-translational modifications, or antibody responses, thereby advancing high-throughput screening and mechanistic studies related to intracellular transport machinery.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency